Jasmijn de Rooij
- Hematology top 5%
- Molecular Biology
- Public Health, Environmental and Occupational Health top 10%
- Oncology
- Pulmonary and Respiratory Medicine
- Co-authors
- C. Michel ZwaanMarry van den Heuvel‐EibrinkMarry M. van den Heuvel‐EibrinkRob PietersEdwin SonneveldJan TrkaDirk ReinhardtSoheil Meshinchi
- Topics
- Acute Myeloid Leukemia Research (10 papers)Acute Lymphoblastic Leukemia research (8 papers)Protein Degradation and Inhibitors (3 papers)
- Partner nations
- NetherlandsFranceCzechia
In The Last Decade
Jasmijn de Rooij
13 papers receiving 462 citations
Peers
Comparison fields: 5 of 56
- Hematology 288
- Molecular Biology 229
- Public Health, Environmental and Occupational Health 153
- Oncology 61
- Pulmonary and Respiratory Medicine 59
Countries citing papers authored by Jasmijn de Rooij
This map shows the geographic impact of Jasmijn de Rooij's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasmijn de Rooij with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasmijn de Rooij more than expected).
Fields of papers citing papers by Jasmijn de Rooij
This network shows the impact of papers produced by Jasmijn de Rooij. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasmijn de Rooij. The network helps show where Jasmijn de Rooij may publish in the future.
Co-authorship network of co-authors of Jasmijn de Rooij
This figure shows the co-authorship network connecting the top 25 collaborators of Jasmijn de Rooij. A scholar is included among the top collaborators of Jasmijn de Rooij based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasmijn de Rooij. Jasmijn de Rooij is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | Molecular genetic aberrations and their prognostic relevance in pediatric acute myeloid leukemia | 1 |
| 3 | 20 | |
| 4 | 72 | |
| 5 | 31 | |
| 6 | 144 | |
| 7 | 15 | |
| 8 | 2 | |
| 9 | 59 | |
| 10 | 1 | |
| 11 | 4 | |
| 12 | 1 | |
| 13 | 95 | |
| 14 | 18 | |
| 15 | 3 |
About Jasmijn de Rooij
Jasmijn de Rooij is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine, having authored 15 papers that have together received 468 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (8 papers) and Protein Degradation and Inhibitors (3 papers). The work is most often cited by research in Hematology (288 citations), Public Health, Environmental and Occupational Health (153 citations) and Genetics (50 citations). Jasmijn de Rooij has collaborated with scholars based in Netherlands, France and Czechia. Frequent co-authors include C. Michel Zwaan, Marry van den Heuvel‐Eibrink, Marry M. van den Heuvel‐Eibrink, Rob Pieters, Edwin Sonneveld, Jan Trka, Dirk Reinhardt, Soheil Meshinchi, Todd A. Alonzo and André Baruchel. Their work appears in journals such as Blood, PLoS ONE and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.